Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years

• Published in: BMC endocrine disorders 2015-08, Vol.15 (1), p.41-41, Article 41
• Main Authors: Ludwig, Ulla, Holzner, Daniela, Denzer, Christian, Greinert, Artur, Haenle, Mark Martin, Oeztuerk, Suemeyra, Koenig, Wolfgang, Boehm, Bernhard Otto, Mason, Richard Andrew, Kratzer, Wolfgang, Graeter, Tilmann
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase - blood; Aspartate Aminotransferases - blood; Cross-Sectional Studies; Diabetes Mellitus - epidemiology; Female; Germany - epidemiology; Humans; Hypertension - epidemiology; Hypothyroidism - blood; Hypothyroidism - epidemiology; Logistic Models; Male; Metabolic Syndrome - epidemiology; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease - blood; Non-alcoholic Fatty Liver Disease - diagnostic imaging; Non-alcoholic Fatty Liver Disease - epidemiology; Overweight - epidemiology; Prevalence; Severity of Illness Index; Thyrotropin - blood; Thyroxine - blood; Triiodothyronine - blood; Ultrasonography; Waist-Hip Ratio; Young Adult
• ISSN: 1472-6823; 1472-6823
• DOI: 10.1186/s12902-015-0030-5

Non-alcoholic fatty liver disease (NAFLD) is one of the most common disorders of the liver worldwide. Recently, a correlation between thyroid dysfunction and NAFLD has been discussed. Objective of the present study was to investigate the association between thyroid dysfunction and hepatic steatosis. Data from 2,445 subjects (51.7% females) aged 18 to 65 years participating in a population-based cross-sectional study were assessed based on a standardized questionnaire and documentation of physical, biochemical and ultrasonographic findings. After application of exclusion criteria, a total of 1,276 subjects were included in the study collective. The influence of potential factors on the development of hepatic steatosis was assessed using multivariate logistic regression. The prevalence of hepatic steatosis in the study collective was 27.4% (n = 349). The serum thyroxin (TT4) concentration in subjects with hepatic steatosis was reduced (p =0.0004). Adjusting for age, or BMI, there was an increased prevalence of hepatic steatosis in subjects with reduced TT4 concentrations (p = 0.0143; p = < .0001). The findings of the present study confirm an association between both subclinical and clinical hypothyroidism and hepatic steatosis.